These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
41 related articles for article (PubMed ID: 2611530)
1. The natriuretic and diuretic responses to the atriopeptidase inhibitor UK-69,578 in volume expanded rats. Barclay PL; Peters CJ; Bennett JA; Danilewicz JC; Samuels GM; Shepperson NB Br J Pharmacol; 1989 Dec; 98 Suppl():824P. PubMed ID: 2611530 [No Abstract] [Full Text] [Related]
2. The natriuretic and diuretic efficacy of atriopeptidase inhibitors following intravenous and oral administration. Shepperson NB; Samuels GM; Barclay PL; Ellis P Br J Pharmacol; 1989 Dec; 98 Suppl():822P. PubMed ID: 2611528 [No Abstract] [Full Text] [Related]
3. The effects of UK-79,300, an orally-absorbed atriopeptidase inhibitor, in a conscious dog model of cardiac insufficiency. Alabaster CT; Machin I; Samuels GM; Sutton MR Br J Pharmacol; 1989 Dec; 98 Suppl():823P. PubMed ID: 2611529 [No Abstract] [Full Text] [Related]
4. Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents. Shepperson NB; Barclay PL; Bennett JA; Samuels GM Clin Sci (Lond); 1991 Mar; 80(3):265-9. PubMed ID: 1850687 [TBL] [Abstract][Full Text] [Related]
6. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Danilewicz JC; Barclay PL; Barnish IT; Brown D; Campbell SF; James K; Samuels GM; Terrett NK; Wythes MJ Biochem Biophys Res Commun; 1989 Oct; 164(1):58-65. PubMed ID: 2529858 [TBL] [Abstract][Full Text] [Related]
7. The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans. Jardine AG; Connell JM; Northridge D; Dilly SG; Cussans NJ; Davidson G; Doyle J; Leckie BL; Lever AF Am J Hypertens; 1990 Sep; 3(9):661-7. PubMed ID: 2145871 [TBL] [Abstract][Full Text] [Related]
8. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863 [TBL] [Abstract][Full Text] [Related]
10. A synthetic deamino-carba-analogue of oxytocin with a raised natriuretic-diuretic effect in rats. Machová A Physiol Bohemoslov; 1983; 32(3):281-4. PubMed ID: 6611712 [No Abstract] [Full Text] [Related]
11. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats. Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759 [TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide and blunted renal responses to volume expansion in rats with Heymann nephritis. Valentin JP; Ying WZ; Sechi LA; Humphreys MH J Hypertens Suppl; 1993 Dec; 11(5):S218-9. PubMed ID: 8158353 [No Abstract] [Full Text] [Related]
13. A humoral component of the natriuretic mechanism in sustained blood volume expansion. Sonnenberg H; Veress AT; Pearce JW J Clin Invest; 1972 Oct; 51(10):2631-44. PubMed ID: 5056659 [TBL] [Abstract][Full Text] [Related]
14. Renal effects of synthetic rat-atrial natriuretic peptide in nephron-reduced rats with nephrotoxic nephritis. Nitta K; Sanaka T; Kawaguchi H; Tsuchiya K; Sone M; Takuma T; Sugino N Jpn J Exp Med; 1987 Feb; 57(1):41-5. PubMed ID: 2957529 [TBL] [Abstract][Full Text] [Related]